Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3C RIMBP3 RIMBP3B	1.46e-05	5	229	3	GO:0030156
GeneOntologyMolecularFunction	phosphatidylcholine transfer activity	ABCA3 PLTP MTTP	2.90e-05	6	229	3	GO:0120019
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DAB2IP ARHGAP40 ARHGEF17 SYDE2 BCAR3 HERC1 TBCD ARAP1 DOCK3 DENND5B ASAP3 DENND11 SYDE1 RGS14 ARHGEF40 GRTP1 ARHGAP33	8.22e-05	507	229	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DAB2IP ARHGAP40 ARHGEF17 SYDE2 BCAR3 HERC1 TBCD ARAP1 DOCK3 DENND5B ASAP3 DENND11 SYDE1 RGS14 ARHGEF40 GRTP1 ARHGAP33	8.22e-05	507	229	17	GO:0030695
GeneOntologyMolecularFunction	medium-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	1.31e-04	2	229	2	GO:0140981
GeneOntologyMolecularFunction	16-hydroxypalmitate dehydrogenase activity	CYP4A11 CYP4A22	1.31e-04	2	229	2	GO:0103002
GeneOntologyMolecularFunction	valine-tRNA ligase activity	VARS1 VARS2	1.31e-04	2	229	2	GO:0004832
GeneOntologyMolecularFunction	phospholipid transfer activity	ABCA3 PLTP PITPNM3 MTTP	2.07e-04	26	229	4	GO:0120014
GeneOntologyMolecularFunction	GTPase activator activity	DAB2IP ARHGAP40 SYDE2 TBCD ARAP1 DOCK3 ASAP3 SYDE1 RGS14 GRTP1 ARHGAP33	3.96e-04	279	229	11	GO:0005096
GeneOntologyMolecularFunction	lipid transfer activity	ABCA3 ABCG5 PLTP PITPNM3 MTTP	4.89e-04	57	229	5	GO:0120013
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	HS3ST1 NDST1 HS3ST5	6.12e-04	15	229	3	GO:0034483
GeneOntologyMolecularFunction	phosphatidylethanolamine transfer activity	PLTP MTTP	7.74e-04	4	229	2	GO:1904121
GeneOntologyBiologicalProcess	organic acid catabolic process	AUH CYP4A11 ALDH8A1 GCDH LPIN1 GLS CYP26C1 ABCD3 ILVBL ARG2 PAH HAAO PCK2	9.31e-06	272	224	13	GO:0016054
GeneOntologyBiologicalProcess	carboxylic acid catabolic process	AUH CYP4A11 ALDH8A1 GCDH LPIN1 GLS CYP26C1 ABCD3 ILVBL ARG2 PAH HAAO PCK2	9.31e-06	272	224	13	GO:0046395
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan metabolic process	SULF2 HS3ST1 NDST1 HS3ST5	2.88e-05	17	224	4	GO:0030201
GeneOntologyCellularComponent	basement membrane	DST PXDN LAD1 LAMA2 LAMA5 LAMB3 HMCN1 MEGF9	6.24e-05	122	230	8	GO:0005604
Domain	SH3_2	CASKIN2 MAP3K11 RIMBP3C SHANK1 DOCK3 RIMBP3 RIMBP3B ARHGAP33	9.58e-06	86	226	8	PF07653
Domain	SH3_2	CASKIN2 MAP3K11 RIMBP3C SHANK1 DOCK3 RIMBP3 RIMBP3B ARHGAP33	9.58e-06	86	226	8	IPR011511
Domain	NUT	NUTM2A NUTM1 NUTM2B	1.72e-05	5	226	3	IPR024310
Domain	NUT_N	NUTM2A NUTM1 NUTM2B	1.72e-05	5	226	3	IPR024309
Domain	NUT	NUTM2A NUTM1 NUTM2B	1.72e-05	5	226	3	PF12881
Domain	-	EPPK1 EVPL DST	3.40e-05	6	226	3	3.90.1290.10
Domain	Plectin	EPPK1 EVPL DST	5.90e-05	7	226	3	PF00681
Domain	Plectin_repeat	EPPK1 EVPL DST	5.90e-05	7	226	3	IPR001101
Domain	PLEC	EPPK1 EVPL DST	5.90e-05	7	226	3	SM00250
Domain	PH_dom-like	DAB2IP LDLRAP1 SPTBN1 SPTBN2 APBB3 ARHGEF17 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3 TNS2 WDFY4 ARHGEF40 TNS1 SNTA1	6.60e-05	426	226	16	IPR011993
Domain	Valyl-tRNA_ligase	VARS1 VARS2	1.46e-04	2	226	2	IPR002303
Domain	Anticodon_Ia_Val	VARS1 VARS2	1.46e-04	2	226	2	IPR033705
Domain	-	DAB2IP LDLRAP1 SPTBN1 SPTBN2 APBB3 ARHGEF17 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3 TNS2 ARHGEF40 TNS1	3.08e-04	391	226	14	2.30.29.30
Domain	Spectrin_repeat	SPTBN1 SPTBN2 EVPL DST	3.91e-04	29	226	4	IPR002017
Domain	PRA1	ARL6IP5 PRAF2	4.34e-04	3	226	2	PF03208
Domain	Prenylated_rab_accept_PRA1	ARL6IP5 PRAF2	4.34e-04	3	226	2	IPR004895
Domain	EGF_LAM_2	LAMA2 LAMA5 LAMB3 MEGF9	4.47e-04	30	226	4	PS50027
Domain	EGF_LAM_1	LAMA2 LAMA5 LAMB3 MEGF9	4.47e-04	30	226	4	PS01248
Domain	SPEC	SPTBN1 SPTBN2 EVPL DST	5.75e-04	32	226	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN1 SPTBN2 EVPL DST	5.75e-04	32	226	4	IPR018159
Domain	EGF_Lam	LAMA2 LAMA5 LAMB3 MEGF9	8.14e-04	35	226	4	SM00180
Domain	Laminin_EGF	LAMA2 LAMA5 LAMB3 MEGF9	8.14e-04	35	226	4	PF00053
Domain	-	MMP2 MMP19	8.61e-04	4	226	2	1.10.101.10
Domain	Spectrin_bsu	SPTBN1 SPTBN2	8.61e-04	4	226	2	IPR016343
Domain	Tensin_PTB	TNS2 TNS1	8.61e-04	4	226	2	IPR033929
Domain	Laminin_N	LAMA2 LAMA5 LAMB3	8.71e-04	16	226	3	IPR008211
Domain	LamNT	LAMA2 LAMA5 LAMB3	8.71e-04	16	226	3	SM00136
Domain	LAMININ_NTER	LAMA2 LAMA5 LAMB3	8.71e-04	16	226	3	PS51117
Domain	Laminin_N	LAMA2 LAMA5 LAMB3	8.71e-04	16	226	3	PF00055
Domain	Laminin_EGF	LAMA2 LAMA5 LAMB3 MEGF9	1.12e-03	38	226	4	IPR002049
Domain	SH3	DST CASKIN2 MAP3K11 RIMBP3C SHANK1 DOCK3 RIMBP3 RIMBP3B ARHGAP33	1.30e-03	216	226	9	PS50002
Domain	PTB	LDLRAP1 APBB3 TNS2 TNS1	1.36e-03	40	226	4	SM00462
Domain	Glyco_hydro_38_C	MAN2C1 MAN2B1	1.42e-03	5	226	2	IPR011682
Domain	Laminin_domII	LAMA2 LAMA5	1.42e-03	5	226	2	IPR010307
Domain	Alpha-mann_mid	MAN2C1 MAN2B1	1.42e-03	5	226	2	PF09261
Domain	Glyco_hydro_57/38_cen	MAN2C1 MAN2B1	1.42e-03	5	226	2	IPR028995
Domain	Glyco_hydro_38	MAN2C1 MAN2B1	1.42e-03	5	226	2	PF01074
Domain	Laminin_aI	LAMA2 LAMA5	1.42e-03	5	226	2	IPR009254
Domain	-	MAN2C1 MAN2B1	1.42e-03	5	226	2	1.20.1270.50
Domain	-	MAN2C1 MAN2B1	1.42e-03	5	226	2	3.20.110.10
Domain	Laminin_I	LAMA2 LAMA5	1.42e-03	5	226	2	PF06008
Domain	Laminin_II	LAMA2 LAMA5	1.42e-03	5	226	2	PF06009
Domain	Alpha-mann_mid	MAN2C1 MAN2B1	1.42e-03	5	226	2	SM00872
Domain	Glyco_hydro_38_N	MAN2C1 MAN2B1	1.42e-03	5	226	2	IPR000602
Domain	Glyco_hydro_38/57_N	MAN2C1 MAN2B1	1.42e-03	5	226	2	IPR027291
Domain	Glyco_hydro_38_cen	MAN2C1 MAN2B1	1.42e-03	5	226	2	IPR015341
Domain	Glyco_hydro_38C	MAN2C1 MAN2B1	1.42e-03	5	226	2	PF07748
Domain	SH3_domain	DST CASKIN2 MAP3K11 RIMBP3C SHANK1 DOCK3 RIMBP3 RIMBP3B ARHGAP33	1.48e-03	220	226	9	IPR001452
Domain	PTB/PI_dom	LDLRAP1 APBB3 TNS2 TNS1	1.49e-03	41	226	4	IPR006020
Domain	PG_binding_1	MMP2 MMP9 MMP19	1.71e-03	20	226	3	PF01471
Domain	Peptidoglycan-bd-like	MMP2 MMP9 MMP19	1.71e-03	20	226	3	IPR002477
Domain	AAA	ABCA3 PSMC5 ABCD3 NAV1 ABCG5 DNAH3 ABCF2	1.87e-03	144	226	7	SM00382
Domain	AAA+_ATPase	ABCA3 PSMC5 ABCD3 NAV1 ABCG5 DNAH3 ABCF2	1.87e-03	144	226	7	IPR003593
Domain	-	DENND5B LOXHD1 ALOXE3	1.98e-03	21	226	3	2.60.60.20
Domain	PLAT	DENND5B LOXHD1 ALOXE3	1.98e-03	21	226	3	PF01477
Domain	PLAT/LH2_dom	DENND5B LOXHD1 ALOXE3	1.98e-03	21	226	3	IPR001024
Domain	PLAT	DENND5B LOXHD1 ALOXE3	1.98e-03	21	226	3	PS50095
Domain	LNS2	LPIN1 PITPNM3	2.12e-03	6	226	2	IPR013209
Domain	LNS2	LPIN1 PITPNM3	2.12e-03	6	226	2	SM00775
Domain	LNS2	LPIN1 PITPNM3	2.12e-03	6	226	2	PF08235
Domain	Val/Leu/Ile-tRNA-synth_edit	VARS1 VARS2	2.12e-03	6	226	2	IPR009008
Domain	Anticodon_1	VARS1 VARS2	2.12e-03	6	226	2	PF08264
Domain	LNS2/PITP	LPIN1 PITPNM3	2.12e-03	6	226	2	IPR031315
Domain	M/V/L/I-tRNA-synth_anticd-bd	VARS1 VARS2	2.12e-03	6	226	2	IPR013155
Domain	-	VARS1 VARS2	2.12e-03	6	226	2	3.90.740.10
Domain	PH	DAB2IP SPTBN1 SPTBN2 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3 ARHGEF40 SNTA1	2.13e-03	278	226	10	SM00233
Domain	PH_DOMAIN	DAB2IP SPTBN1 SPTBN2 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3 ARHGEF40 SNTA1	2.19e-03	279	226	10	PS50003
Domain	PH_domain	DAB2IP SPTBN1 SPTBN2 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3 ARHGEF40 SNTA1	2.25e-03	280	226	10	IPR001849
Domain	SH3_9	MAP3K11 RIMBP3C RIMBP3 RIMBP3B ARHGAP33	2.56e-03	78	226	5	PF14604
Domain	Hemopexin-like_dom	MMP2 MMP9 MMP19	2.59e-03	23	226	3	IPR000585
Domain	Hemopexin-like_repeat	MMP2 MMP9 MMP19	2.59e-03	23	226	3	IPR018487
Domain	Spectrin	SPTBN1 SPTBN2 DST	2.59e-03	23	226	3	PF00435
Domain	HEMOPEXIN	MMP2 MMP9 MMP19	2.59e-03	23	226	3	PS00024
Domain	ACTININ_2	SPTBN1 SPTBN2 DST	2.59e-03	23	226	3	PS00020
Domain	-	MMP2 MMP9 MMP19	2.59e-03	23	226	3	2.110.10.10
Domain	HEMOPEXIN_2	MMP2 MMP9 MMP19	2.59e-03	23	226	3	PS51642
Domain	ACTININ_1	SPTBN1 SPTBN2 DST	2.59e-03	23	226	3	PS00019
Domain	HX	MMP2 MMP9 MMP19	2.59e-03	23	226	3	SM00120
Domain	Actinin_actin-bd_CS	SPTBN1 SPTBN2 DST	2.59e-03	23	226	3	IPR001589
Domain	M10A_MMP	MMP2 MMP9 MMP19	2.59e-03	23	226	3	IPR033739
Domain	Hemopexin	MMP2 MMP9 MMP19	2.59e-03	23	226	3	PF00045
Domain	Pept_M10A	MMP2 MMP9 MMP19	2.59e-03	23	226	3	IPR021190
Domain	ABC_tran	ABCA3 ABCD3 ABCG5 ABCF2	2.68e-03	48	226	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCA3 ABCD3 ABCG5 ABCF2	2.68e-03	48	226	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCA3 ABCD3 ABCG5 ABCF2	2.89e-03	49	226	4	PS00211
Domain	Peptidase_M10	MMP2 MMP9 MMP19	2.93e-03	24	226	3	PF00413
Domain	aa-tRNA-synth_Ia	VARS1 VARS2	2.94e-03	7	226	2	IPR002300
Domain	tRNA-synt_1	VARS1 VARS2	2.94e-03	7	226	2	PF00133
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2C1 MAN2B1	2.94e-03	7	226	2	IPR011330
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP EPPK1 MAN2B1 APBB3 PLEKHM1 DST KCNJ11 RRP12 NAV1 MAP3K11 HERC1 TBCD ARAP1 AGTRAP UNC13B DOCK3 NDST1 FAM193B TSNARE1 KHNYN LAD1 LAMA5 LAMB3 RELB FRYL BAHD1 FAM83H ARHGEF40 GRTP1 BTBD7 HMGXB3 ARHGAP33	5.49e-12	1105	236	32	35748872
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	RNF112 SPTBN2 EVPL ARHGEF17 QRICH2 DST SYDE2 ABCD3 MMP2 TICRR DNAH3 KIF26B LARP1 LAMB3 PIWIL2 ARCN1 KIAA1671 LOXHD1 PITPNM3 POTEA CNOT1	3.90e-08	736	236	21	29676528
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IFT140 MLEC WDR43 SULF2 DST SYNJ2 CASKIN2 KCNT1 ARAP1 LARP1 LAMA5 BAHD1 UBE2O ANKRD17 HMGXB3 HERC4 CNOT1	1.54e-07	529	236	17	14621295
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	LDLRAP1 ZNF133 MLEC SPTBN1 SPTBN2 APBB3 PLEKHH1 DST GLS MAP3K11 VARS1 MTUS2 SHANK1 UNC13B DOCK3 NDST1 PMS2 ANK2 CNRIP1 SIAH1 TRIM68 BTBD2 ARCN1 ARG2 UBE2O MEGF9 SNTA1	2.26e-07	1285	236	27	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP MBTPS1 ARHGEF17 PLEKHH1 PXDN FBXO28 RRP12 NAV1 UNC13B ZSWIM5 KHNYN DENND11 MEGF9 BTBD7	8.89e-07	407	236	14	12693553
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP MLEC PDK1 SPTBN1 RYR2 AK3 GLS ABCD3 NAV1 VARS1 SHANK1 DOCK3 ANK2 U2SURP ARL6IP5 ARCN1 SLC6A11 DZANK1 UBE2O PITPNM3 CNDP2 CNOT1 PCK2 TP53BP1	1.06e-06	1139	236	24	36417873
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3C RIMBP3 RIMBP3B	1.23e-06	4	236	3	19091768
Pubmed	The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.	ETV4 MMP2 MMP9	1.23e-06	4	236	3	18644862
Pubmed	Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.	MBTPS1 CYP4A11 HMGCS2 ACSS2 ABCD3 MMP9 ABCG5 PLTP RELB PCK2 ARHGAP33	1.28e-06	250	236	11	18660489
Pubmed	Specific 3-O-sulfated heparan sulfate domains regulate salivary gland basement membrane metabolism and epithelial differentiation.	ETV4 MMP2 HS3ST1 NDST1 LAMA5 HS3ST5 LAMB3	1.38e-06	81	236	7	39217171
Pubmed	A human MAP kinase interactome.	IFT140 SPTBN1 SPTBN2 EVPL MIDEAS DST SYNJ2 NAV1 MAP3K11 SHANK1 KIF26B LCP2 ANKRD17 TNS1 ARHGAP33	1.39e-06	486	236	15	20936779
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 SPTBN1 SPTBN2 KRI1 PSMC5 WDR43 DST RRP12 POLR1A U2SURP LARP1 FRYL UBE2O ANKRD17 LAS1L CNOT1 TP53BP1	2.77e-06	653	236	17	22586326
Pubmed	Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.	ETV4 MMP2 MMP9	3.05e-06	5	236	3	25544710
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3C RIMBP3 RIMBP3B	3.05e-06	5	236	3	17855024
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	IFT140 SPTBN2 DST SYNJ2 RRP12 NAV1 U2SURP BAHD1	3.18e-06	130	236	8	12421765
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MLEC SPTBN1 SPTBN2 KRI1 PSMC5 GCDH DST PXDN RRP12 ABCD3 PYCR1 UMPS ILVBL DUT LARP1 ABCF2 RELB ARCN1 CCNB1 ARG2 KIAA1671 LAS1L MRPL11 CNOT1 MRPL1 PCK2	6.15e-06	1440	236	26	30833792
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SPTBN2 ARHGEF17 PLEKHM1 SYNJ2 DOCK3 U2SURP KHNYN	7.36e-06	104	236	7	9205841
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SPTBN1 EVPL LPIN1 DST ANLN TCAF2 LAD1 LARP1 TRIM16 IGFBP7 CNDP2 TP53BP1	7.44e-06	360	236	12	33111431
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	RNF112 PXDN RRP12 LARP1 FRYL ARHGEF40 MTTP ANKRD17 CNOT1	1.09e-05	202	236	9	33005030
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	MAN2C1 KRI1 PSMC5 ABCD3 PYCR1 ILVBL UNC13B DNHD1 CARMIL2 U2SURP LARP1 CNRIP1 CUBN UBE2O LAS1L TP53BP1	1.59e-05	670	236	16	22990118
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EPPK1 SPTBN1 SPTBN2 KRI1 EVPL WDR43 DST ANLN RRP12 GLS ABCD3 NAV1 LAD1 LARP1 LAMB3 ABCF2 ARCN1 FAM83H KIAA1671 ANKRD17 SMARCD2 LAS1L MRPL11	1.77e-05	1257	236	23	36526897
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	AUH SPTBN1 SPTBN2 TRPM2 NUTM2A KRI1 WDR76 MIDEAS WDR43 PYCR1 UMPS VARS1 UNC13B ANK2 LAD1 LARP1 VARS2 ARCN1 ARHGEF40 ANKRD17 SMARCD2 LAS1L CNOT1 PCK2	2.36e-05	1371	236	24	36244648
Pubmed	Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.	MMP2 MMP9 LAMA5	2.51e-05	9	236	3	10880400
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PSMC5 GCDH PXDN RRP12 MTX3 ABCD3 UMPS VARS1 ILVBL TBCD POLR1A ABCF2 ARCN1 CCNB1 UBE2O ARHGEF40 ANKRD17 PRAF2 PCK2	2.67e-05	942	236	19	31073040
Pubmed	Phospho-tyrosine dependent protein-protein interaction network.	IFT140 APBB3 ANLN SHE BCAR3 MGARP TNS2 E2F6 LCP2 TCAP CNDP2 TNS1	2.70e-05	410	236	12	25814554
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SPTBN1 ARHGEF17 DST SYNJ2 CASKIN2 ANLN SYDE2 NAV1 CARMIL2 KIF26B LARP1 FRYL TRIM68 SYDE1 E2F8 FAM83H KIAA1671 ANKRD17	2.75e-05	861	236	18	36931259
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTBN1 SPTBN2 ANK2	3.57e-05	10	236	3	22159418
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA2 LAMA5 LAMB3	3.57e-05	10	236	3	9034910
Pubmed	Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells.	MMP2 MMP9	4.59e-05	2	236	2	26134921
Pubmed	Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features.	MMP2 MMP9	4.59e-05	2	236	2	32394348
Pubmed	Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.	MMP2 MMP9	4.59e-05	2	236	2	19074020
Pubmed	Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.	MMP2 MMP9	4.59e-05	2	236	2	20129576
Pubmed	Increased activity and expression of gelatinases in ischemic colitis.	MMP2 MMP9	4.59e-05	2	236	2	17089188
Pubmed	Genetic variation in matrix metalloproteinase MMP2 and MMP9 as a risk factor for idiopathic recurrent spontaneous abortions in an Indian population.	MMP2 MMP9	4.59e-05	2	236	2	28500450
Pubmed	Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.	MMP2 MMP9	4.59e-05	2	236	2	26588471
Pubmed	Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis.	MMP2 MMP9	4.59e-05	2	236	2	23257253
Pubmed	MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.	MMP2 MMP9	4.59e-05	2	236	2	21707819
Pubmed	Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.	CYP4A11 CYP4A22	4.59e-05	2	236	2	15611369
Pubmed	Matrix metalloproteinase (MMP)-9: A realiable marker for inflammation in early human trichinellosis.	MMP2 MMP9	4.59e-05	2	236	2	27117947
Pubmed	In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.	MMP2 MMP9	4.59e-05	2	236	2	24823643
Pubmed	Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.	MMP2 MMP9	4.59e-05	2	236	2	18187184
Pubmed	Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.	MMP2 MMP9	4.59e-05	2	236	2	26097608
Pubmed	Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?	MMP2 MMP9	4.59e-05	2	236	2	17949555
Pubmed	Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.	MMP2 MMP9	4.59e-05	2	236	2	19509016
Pubmed	Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.	MMP2 MMP9	4.59e-05	2	236	2	20372784
Pubmed	Implication of matrix metalloproteinases 2 and 9 in ceramide 1-phosphate-stimulated macrophage migration.	MMP2 MMP9	4.59e-05	2	236	2	27164414
Pubmed	Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.	MMP2 MMP9	4.59e-05	2	236	2	15609121
Pubmed	Role of gelatinases in disuse-induced skeletal muscle atrophy.	MMP2 MMP9	4.59e-05	2	236	2	19790245
Pubmed	Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells.	MMP2 MMP9	4.59e-05	2	236	2	15672417
Pubmed	Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.	MMP2 MMP9	4.59e-05	2	236	2	12967855
Pubmed	Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.	MMP2 MMP9	4.59e-05	2	236	2	10201949
Pubmed	Disruption of CADM1-dependent cell-cell adhesion in human oral squamous cell carcinoma cells results in tumor progression, possibly through an increase of MMP-2 and MMP-9 expression.	MMP2 MMP9	4.59e-05	2	236	2	38030062
Pubmed	A novel brain-specific isoform of beta spectrin: isolation and its interaction with Munc13.	SPTBN2 UNC13B	4.59e-05	2	236	2	9704016
Pubmed	Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase.	HS3ST1 NDST1	4.59e-05	2	236	2	9346953
Pubmed	Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque.	MMP2 MMP9	4.59e-05	2	236	2	21334624
Pubmed	The Inhibitory Effect of C-phycocyanin Containing Protein Extract (C-PC Extract) on Human Matrix Metalloproteinases (MMP-2 and MMP-9) in Hepatocellular Cancer Cell Line (HepG2).	MMP2 MMP9	4.59e-05	2	236	2	28357609
Pubmed	Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.	MMP2 MMP9	4.59e-05	2	236	2	21611966
Pubmed	Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.	MMP2 MMP9	4.59e-05	2	236	2	25966235
Pubmed	Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.	MMP2 MMP9	4.59e-05	2	236	2	14981939
Pubmed	The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line.	MMP2 MMP9	4.59e-05	2	236	2	20563853
Pubmed	Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.	MMP2 MMP9	4.59e-05	2	236	2	28440509
Pubmed	Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.	MMP2 MMP9	4.59e-05	2	236	2	21958210
Pubmed	Inhibitory effects of tetrandrine on epidermal growth factor-induced invasion and migration in HT29 human colorectal adenocarcinoma cells.	MMP2 MMP9	4.59e-05	2	236	2	26648313
Pubmed	The expression pattern of laminin isoforms in Hirschsprung disease reveals a distal peripheral nerve differentiation.	LAMA2 LAMA5	4.59e-05	2	236	2	16226104
Pubmed	Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.	MMP2 MMP9	4.59e-05	2	236	2	19574670
Pubmed	Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.	TNS2 TNS1	4.59e-05	2	236	2	11792844
Pubmed	Inhibition of MMP-2 and MMP-9 attenuates surgery-induced cognitive impairment in aged mice.	MMP2 MMP9	4.59e-05	2	236	2	37939860
Pubmed	Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.	MMP2 MMP9	4.59e-05	2	236	2	26866436
Pubmed	Congenital Muscular Dystrophy 1D Causes Matrix Metalloproteinase Activation And Blood-Brain Barrier Impairment.	MMP2 MMP9	4.59e-05	2	236	2	27915985
Pubmed	The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms.	MMP2 MMP9	4.59e-05	2	236	2	16961137
Pubmed	Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.	MMP2 MMP9	4.59e-05	2	236	2	33568081
Pubmed	Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling.	MMP2 MMP9	4.59e-05	2	236	2	15998676
Pubmed	The Polyploid State Plays a Tumor-Suppressive Role in the Liver.	ANLN E2F8	4.59e-05	2	236	2	29429824
Pubmed	Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.	MMP2 MMP9	4.59e-05	2	236	2	16313894
Pubmed	Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques.	MMP2 MMP9	4.59e-05	2	236	2	29190653
Pubmed	[Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma].	MMP2 MMP9	4.59e-05	2	236	2	20501425
Pubmed	Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.	MMP2 MMP9	4.59e-05	2	236	2	19165813
Pubmed	[Association of gene polymorphisms of matrix metalloproteinases with reproductive losses in the first trimester of pregnancy].	MMP2 MMP9	4.59e-05	2	236	2	29369548
Pubmed	Combination of ACY-241 and JQ1 Synergistically Suppresses Metastasis of HNSCC via Regulation of MMP-2 and MMP-9.	MMP2 MMP9	4.59e-05	2	236	2	32961679
Pubmed	GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary.	MMP2 MMP9	4.59e-05	2	236	2	21454403
Pubmed	Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.	MMP2 MMP9	4.59e-05	2	236	2	18081721
Pubmed	Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro.	MMP2 MMP9	4.59e-05	2	236	2	9087449
Pubmed	Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage.	MMP2 MMP9	4.59e-05	2	236	2	30248101
Pubmed	MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.	MMP2 MMP9	4.59e-05	2	236	2	30548095
Pubmed	Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection.	MMP2 MMP9	4.59e-05	2	236	2	15707406
Pubmed	Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.	MMP2 MMP9	4.59e-05	2	236	2	12208863
Pubmed	Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.	MMP2 MMP9	4.59e-05	2	236	2	28633655
Pubmed	Matrix metalloproteinase expression and activity in trophoblast-decidual tissues at organogenesis in CF-1 mouse.	MMP2 MMP9	4.59e-05	2	236	2	22714107
Pubmed	Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).	MMP2 MMP9	4.59e-05	2	236	2	19523650
Pubmed	Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.	MMP2 MMP9	4.59e-05	2	236	2	28669039
Pubmed	Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.	MMP2 MMP9	4.59e-05	2	236	2	12642591
Pubmed	Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran.	MMP2 MMP9	4.59e-05	2	236	2	38708584
Pubmed	Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas: preliminary findings.	MMP2 MMP9	4.59e-05	2	236	2	19716817
Pubmed	Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases.	MMP2 MMP9	4.59e-05	2	236	2	27589705
Pubmed	Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.	MMP2 MMP9	4.59e-05	2	236	2	16718267
Pubmed	Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.	MMP2 MMP9	4.59e-05	2	236	2	14736853
Pubmed	Expression of matrix metalloproteinases 2 and 9 in donor liver, cirrhotic liver, and acute rejection after human liver transplantation.	MMP2 MMP9	4.59e-05	2	236	2	19100442
Pubmed	[Inhibitory effect of curcumin on MMP-2 and MMP-9 expression induced by polyethylene wear particles and its mechanism].	MMP2 MMP9	4.59e-05	2	236	2	19594013
Pubmed	The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.	MMP2 MMP9	4.59e-05	2	236	2	28719899
Pubmed	Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.	MMP2 MMP9	4.59e-05	2	236	2	12569569
Interaction	TOP3B interactions	DAB2IP EPPK1 MAN2B1 SPTBN2 APBB3 PLEKHM1 DST KCNJ11 RRP12 NAV1 MAP3K11 HERC1 TSR3 TBCD ARAP1 AGTRAP UNC13B DOCK3 NDST1 FAM193B TSNARE1 KHNYN LAD1 LAMA5 LAMB3 RELB FRYL BAHD1 FAM83H ARHGEF40 GRTP1 BTBD7 ANKRD17 HMGXB3 MRPL11 CNOT1 ARHGAP33 TP53BP1	1.24e-06	1470	227	38	int:TOP3B
Interaction	IL5RA interactions	MBTPS1 MAN2B1 CHRNA5 SULF2 PXDN HSD17B1 HS3ST1 LAMA5 LAMB3	1.15e-05	124	227	9	int:IL5RA
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 EVPL DST	2.69e-05	8	144	3	939
GeneFamily	Laminin subunits	LAMA2 LAMA5 LAMB3	1.03e-04	12	144	3	626
GeneFamily	Ankyrin repeat domain containing	CASKIN2 GLS ARAP1 SHANK1 ANK2 ASAP3 DZANK1 ANKRD17 POTEA	1.41e-04	242	144	9	403
GeneFamily	Mannosidases alpha class 2	MAN2C1 MAN2B1	6.20e-04	5	144	2	1194
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TNS2 TNS1	6.20e-04	5	144	2	902
GeneFamily	YIP family	ARL6IP5 PRAF2	6.20e-04	5	144	2	1144
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP2 MMP9 MMP19	8.86e-04	24	144	3	891
GeneFamily	SH2 domain containing	SHE BCAR3 TNS2 LCP2 TNS1	1.28e-03	101	144	5	741
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN1 SPTBN2	1.29e-03	7	144	2	1113
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTBN1 SPTBN2 PLEKHM1 PLEKHH1 ANLN ARAP1 ASAP3	1.33e-03	206	144	7	682
GeneFamily	E2F transcription factors	E2F6 E2F8	1.71e-03	8	144	2	982
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TNS2 TNS1	1.71e-03	8	144	2	837
GeneFamily	Sulfotransferases, membrane bound	HS3ST1 NDST1 HS3ST5	3.15e-03	37	144	3	763
GeneFamily	Sterile alpha motif domain containing	SGMS1 CASKIN2 ARAP1 SHANK1	5.37e-03	88	144	4	760
ToppCell	droplet-Fat-Mat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 LRRC32 RYR2 DST SHE UNC13B LAMA5 KIAA1671 TNS1	8.79e-08	193	236	10	54024a373e42e1c0bcc327dc084564b83b63a9d4
ToppCell	droplet-Fat-Mat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 LRRC32 RYR2 DST SHE UNC13B LAMA5 KIAA1671 TNS1	8.79e-08	193	236	10	81d908594d2983ba7e7c1ec25afdde4315d9690e
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYCR1 MMP2 GPR17 LAD1 ASAP3 CUBN E2F8 RIMBP3 GRTP1	2.41e-07	164	236	9	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ETV4 CASKIN2 NAV1 MMP2 MGARP GPR17 LAD1	5.16e-07	90	236	7	a0baaf2b3cf07d457f0d242fc213689cba6fd449
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ETV4 CASKIN2 NAV1 MMP2 MGARP GPR17 LAD1	5.16e-07	90	236	7	ab4b08c6ac8695b38f841c0ecf2bb2c032111d04
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 SLITRK2 UNC79 KIF26B MROH2A GRIK3 LOXHD1 HMCN1 MYOCD	6.36e-07	184	236	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 SLITRK2 UNC79 KIF26B MROH2A GRIK3 LOXHD1 HMCN1 MYOCD	6.36e-07	184	236	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 SLITRK2 UNC79 KIF26B MROH2A GRIK3 LOXHD1 HMCN1 MYOCD	6.36e-07	184	236	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 MCM10 WDR76 ANLN TICRR POLH E2F8 CCNB1 ARHGAP33	6.66e-07	185	236	9	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	HMGCS2 LPIN1 SULF2 DST PXDN MMP2 ANK2 LAMA2 MYOCD	6.96e-07	186	236	9	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 DRAXIN PYCR1 MMP2 TICRR GPR17 PABPC4L E2F8 CCNB1	7.28e-07	187	236	9	dbcec24d2c852964736c78e9d81650bff5c455ae
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 DRAXIN PYCR1 MMP2 TICRR GPR17 PABPC4L E2F8 CCNB1	7.28e-07	187	236	9	38ee33295a21db4aae5ba085df033db9693e41c6
ToppCell	CV-Healthy-2\|Healthy / Virus stimulation, Condition and Cluster	ORC6 TRPM2 MCM10 ANLN RRP12 PYCR1 TICRR ABCF2 E2F8	9.07e-07	192	236	9	a249787f7e2f50af49bd7d4752c411a067a5e3d3
ToppCell	droplet-Fat-Mat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP LRRC32 RYR2 DST SHE UNC13B LAMA5 KIAA1671 TNS1	9.89e-07	194	236	9	74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ORC6 DESI1 PLTP NRIP3 CCNB1 GRTP1 HMCN1 ENTPD8	2.51e-06	162	236	8	1f1b93394b1f27cbb76b369c19b9313609edd577
ToppCell	Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ARHGEF17 DENND5B GPR17 ANK2 KHNYN GRIK3	2.87e-06	116	236	7	b0a3c109c5f20ab699e53bf8ab3903d102f5f315
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SPTBN2 TRPM2 DACT2 UNC79 SHANK1 GRIK3 NRIP3 FAM83H	3.15e-06	167	236	8	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SPTBN2 TRPM2 DACT2 UNC79 SHANK1 GRIK3 NRIP3 FAM83H	3.15e-06	167	236	8	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 ACSS2 LPIN1 ABCD3 FABP12 PAH CNDP2 HAAO	3.44e-06	169	236	8	ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 ACSS2 LPIN1 ABCD3 FABP12 PAH CNDP2 HAAO	3.44e-06	169	236	8	922086f218135b734b7d370b871923e50141edce
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	DHRS13 MTX3 NDST1 TICRR FAM193B CARMIL2 VARS2	6.42e-06	131	236	7	88b3298110bc2333ffa202a3f41ac0d24e2308c7
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM2 SULF2 MMP9 HS3ST1 PLTP NRIP3 ARHGEF40 TNS1	6.70e-06	185	236	8	29d7ddcb9a2e45f76cd5611f7c52b6df689effd3
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM2 SULF2 MMP9 HS3ST1 PLTP NRIP3 ARHGEF40 TNS1	6.70e-06	185	236	8	780bdb63ef913a09930063286011c9108381d3a9
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TRPM2 SULF2 MMP9 HS3ST1 PLTP NRIP3 ARHGEF40 TNS1	6.70e-06	185	236	8	274b8acccdfe434d14af4cb32fb615c06ec98435
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRPM2 SULF2 MMP9 HS3ST1 PLTP NRIP3 ARHGEF40 TNS1	6.70e-06	185	236	8	b640d9ed6a1e6aa595053065bb992efc0402353e
ToppCell	356C-Endothelial_cells-Endothelial-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYT12 LRRC32 QRICH2 PXDN CASKIN2 NDST1 CUBN FAM124B	6.97e-06	186	236	8	2e024097ee361eeb1d855a4edb8ac8cdad35da06
ToppCell	356C-Endothelial_cells-Endothelial-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYT12 LRRC32 QRICH2 PXDN CASKIN2 NDST1 CUBN FAM124B	6.97e-06	186	236	8	c3449e54454009973818fc1101933c6f0168258c
ToppCell	Control-Myeloid-MoAM3,_VCAN\|Myeloid / Condition, Lineage and Cell class	SPTBN1 TRPM2 SYNJ2 MMP2 HS3ST1 ARHGEF40 IGFBP7 TNS1	6.97e-06	186	236	8	0bf16ac48931b62bb3c33d63ff4279654148e293
ToppCell	mild_COVID-19-Plasmablast\|mild_COVID-19 / disease group, cell group and cell class (v2)	ETV4 MCM10 KCNN3 PYCR1 DENND5B TICRR E2F8 CCNB1	6.97e-06	186	236	8	a639d2183b85b1be6e6da2b2e112aec5149d5bcd
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 GCDH ABCD3 CUBN SLC3A1 IGFBP7 PAH TNS1	7.24e-06	187	236	8	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	LRRC32 SULF2 OLFML1 MMP2 KIF26B LAMA2 HMCN1 TNN	7.24e-06	187	236	8	a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 MCM10 WDR76 ANLN TICRR POLH E2F8 CCNB1	7.24e-06	187	236	8	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 DRAXIN PYCR1 TICRR GPR17 PABPC4L E2F8 CCNB1	7.24e-06	187	236	8	a2076599b33ae6750961b573bfebcb9036fa4ee8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ORC6 ZGRF1 MCM10 ANLN TICRR POLH CCNB1 ARHGAP33	7.24e-06	187	236	8	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MCM10 WDR76 ANLN TICRR LCP2 WDFY4 E2F8 CSF1R	7.24e-06	187	236	8	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	mild_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	MCM10 ANLN KCNN3 PYCR1 DENND5B TICRR E2F8 CCNB1	7.53e-06	188	236	8	9a5ba6abdc307402301dae25db2a5f3e0d576417
ToppCell	Endothelial-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ORC6 WDR76 ARHGEF17 KCNN3 UMPS SHE HS3ST1 IGFBP7	7.53e-06	188	236	8	ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SULF2 KCNN3 SHE HS3ST1 KIF26B KIAA1671 HMCN1 IGFBP7	7.53e-06	188	236	8	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRC32 SULF2 NAV1 KCNN3 SHE KIAA1671 HMCN1 FAM124B	7.83e-06	189	236	8	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGCS2 RYR2 SULF2 MMP2 ANK2 LAMA2 ARHGEF40 MYOCD	8.14e-06	190	236	8	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRC32 SYNJ2 NAV1 KCNN3 SHE KIAA1671 HMCN1 FAM124B	8.14e-06	190	236	8	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 MYOCD	8.14e-06	190	236	8	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	8.46e-06	191	236	8	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	LRRC32 ARHGEF17 RYR2 PXDN KCNT1 HMCN1 IGFBP7 MYOCD	8.46e-06	191	236	8	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	DAB2IP SPTBN1 DST PXDN NDST1 LAMA5 LAMB3 IGFBP7	8.78e-06	192	236	8	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 LRRC32 SULF2 NAV1 KCNN3 SHE PCDH11Y KIAA1671	8.78e-06	192	236	8	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	Control-Myeloid-MoAM4\|Control / Disease group,lineage and cell class （2021.01.30）	TRPM2 SULF2 MMP9 HS3ST1 PLTP NRIP3 ARHGEF40 TNS1	8.78e-06	192	236	8	1da7c303a2e36af4a9d8ec30a11380d9b1897922
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 MYOCD	9.12e-06	193	236	8	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	CTRL-Myeloid-Monocyte_Macrophage\|Myeloid / Disease state, Lineage and Cell class	SPTBN1 TRPM2 SULF2 MMP9 CMAHP HS3ST1 NRIP3 IGFBP7	9.47e-06	194	236	8	73459ee062ae1f1a3bb9719dc0b89aae10600e22
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR POLH E2F8	9.47e-06	194	236	8	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM10 ANLN KCNN3 PYCR1 DENND5B TICRR E2F8 CCNB1	9.47e-06	194	236	8	5a519538327029ad2b880ef9647e2ac6ab3961a4
ToppCell	3'_v3-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	ORC6 ZGRF1 MCM10 WDR76 ANLN DUT E2F8 IGFBP7	9.47e-06	194	236	8	bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRC32 ARHGEF17 OLFML1 MMP9 SYDE1 IGFBP7 DCLK3 MYOCD	9.47e-06	194	236	8	a7731378f44ca1a229311686caf5740c742d21ba
ToppCell	control-Lymphocytic-Prol._cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	9.47e-06	194	236	8	4c76508de3291c952386caffda2d559629ba5998
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	9.83e-06	195	236	8	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	droplet-Kidney-nan-3m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 AK3 DST ABCD3 LAD1 IGFBP7 PAH TNS1	1.02e-05	196	236	8	9f39cb3de886283da34ee7511a92d94930a6c851
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR POLH E2F8	1.02e-05	196	236	8	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRC32 ARHGEF17 OLFML1 MMP9 CCNB1 IGFBP7 DCLK3 HAAO	1.02e-05	196	236	8	cb5860f580b477bfa52b22cdc21b808e1371e6e0
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)\|lymph-node_spleen / Manually curated celltypes from each tissue	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	1.02e-05	196	236	8	32d54c0b487f00c4f8bd765462e484da8a6625c9
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ORC6 ZGRF1 MCM10 ANLN TICRR KIF26B LAMA2 CCNB1	1.02e-05	196	236	8	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	1.02e-05	196	236	8	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T\|lymph-node_spleen / Manually curated celltypes from each tissue	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	1.06e-05	197	236	8	aca6cbff7391ff550061bb7daa67fc5f6585806a
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	ORC6 ZGRF1 MCM10 ANLN TICRR E2F8 CCNB1 IGFBP7	1.10e-05	198	236	8	b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCell	distal-3-Hematologic-Proliferating_NK/T\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC6 MCM10 WDR76 ANLN ZYG11A TICRR E2F8 ARHGAP33	1.10e-05	198	236	8	aa23119d73554733981df474648e59918d04edfc
ToppCell	(0)_NK_cells-(0)_NK_Dividing\|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	1.10e-05	198	236	8	d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	1.10e-05	198	236	8	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC32 ARHGEF17 RYR2 KCNT1 LAMA5 IGFBP7 MYOCD TNS1	1.10e-05	198	236	8	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	erythropoietic-Basophilic_Erythroblast\|World / Lineage and Cell class	ORC6 MCM10 PYCR1 PLTP CNRIP1 CCNB1 GRTP1 FAM124B	1.10e-05	198	236	8	b3db4db02c0e659163cefb3d83f53e4940cc04bf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP4A11 ALDH8A1 SMIM32 ANK2 CUBN SLC3A1 PAH PCK2	1.10e-05	198	236	8	72733b6149b797ac11cc108bc80428b77fbbba78
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC6 MCM10 WDR76 CHRNA5 ANLN TICRR E2F8 CCNB1	1.10e-05	198	236	8	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	distal-Hematologic-Proliferating_NK/T-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC6 MCM10 WDR76 ANLN ZYG11A TICRR E2F8 ARHGAP33	1.10e-05	198	236	8	5c14b152912429f099dfcb6bcb1aec80314a3284
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	1.10e-05	198	236	8	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP4A11 ALDH8A1 SMIM32 ANK2 CUBN SLC3A1 PAH PCK2	1.10e-05	198	236	8	f23559ce6072e3c323f6791ff95269271b0f7ff1
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SPTBN2 ETV4 EVPL WDR43 RRP12 E2F6 CCNB1 METTL2B	1.14e-05	199	236	8	cdcdef1d95a8e476de016b1e11ee010438834be0
ToppCell	normal_Lymph_Node-T/NK_cells-Undetermined\|normal_Lymph_Node / Location, Cell class and cell subclass	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	1.14e-05	199	236	8	cefcfe639a3396bccf2354ca605a1e18b964fbf2
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	SULF2 DST PXDN MMP2 MMP9 LAMB3 ARHGEF40 IGFBP7	1.14e-05	199	236	8	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	distal-Hematologic-Proliferating_NK/T\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC6 MCM10 WDR76 ANLN TICRR E2F8 CCNB1 ARHGAP33	1.14e-05	199	236	8	4f02e03c118744fba0dfc5e3ed6dea4041f3d089
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTBN1 DST MMP2 ANK2 KIF26B NRIP3 IGFBP7 TNS1	1.18e-05	200	236	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZGRF1 MCM10 WDR76 ANLN TICRR TRIM68 E2F8 CCNB1	1.18e-05	200	236	8	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	1.18e-05	200	236	8	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	3'_v3-Lung-Lymphocytic_NK-Cycling_NK\|Lung / Manually curated celltypes from each tissue	ORC6 ZGRF1 MCM10 WDR76 ANLN E2F8 CCNB1 IGFBP7	1.18e-05	200	236	8	381bafdde6492f020ae93ab8fffa6215c631c570
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 ARHGAP33	1.18e-05	200	236	8	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	BL-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ORC6 ZGRF1 MCM10 WDR76 ANLN TICRR E2F8 CCNB1	1.18e-05	200	236	8	04d95a9102248e98eed069840ea6d3d23a243fd5
ToppCell	severe-cDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SULF2 DST NAV1 WDFY4 CSF1R IGFBP7 CNDP2 HAAO	1.18e-05	200	236	8	26e04ea276dbca5cde48335c401269c7123b54d2
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SLITRK2 PXDN OLFML1 NKPD1 MMP2 MGARP ANK2 LAMA2	1.18e-05	200	236	8	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	NS-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ORC6 MCM10 WDR76 ANLN TICRR DUT E2F8 CCNB1	1.18e-05	200	236	8	d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTBN1 LRRC32 CASKIN2 MAP3K11 SHE KIAA1671 IGFBP7 FAM124B	1.18e-05	200	236	8	90061284a80d29a4ca6078f578e13d32b8cc80e1
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate\|3m / Sample Type, Dataset, Time_group, and Cell type.	PDK1 APBB3 MAP3K11 HS3ST1 LARP1 NRIP3 ARG2 ANKRD17	1.18e-05	200	236	8	cbd0b9188a94778ffa539912aeb2a4378f0ab88f
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLEKHH1 OLFML1 CASKIN2 ANLN GPR17 LAD1 E2F8	1.56e-05	150	236	7	b30f52b94ce772632a1f2f5e0837db876cf92651
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLEKHH1 OLFML1 CASKIN2 ANLN GPR17 LAD1 E2F8	1.56e-05	150	236	7	05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a
ToppCell	facs-Lung-EPCAM-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ORC6 PLTP NRIP3 E2F8 CCNB1 GRTP1 ENTPD8	1.92e-05	155	236	7	0e942609d3e060f1e589fee5997fc6299f3d18bc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DAB2IP LRRC32 MAMSTR TBCD TICRR RELB TCAP	1.92e-05	155	236	7	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ORC6 PLTP NRIP3 E2F8 CCNB1 GRTP1 ENTPD8	2.01e-05	156	236	7	bb64bf520cb74897a01c64924a85a1550df2b801
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GP6 RYR2 SYNJ2 MMP19 DNHD1 MROH2A HAAO	2.18e-05	158	236	7	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	RYR2 SLITRK2 LAMA2 POM121L2 TNS2 HMCN1 TNS1	2.27e-05	159	236	7	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_12\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ORC6 WDR76 KCNN3 PYCR1 MMP9 TICRR USP37	2.46e-05	161	236	7	1670108afc0af90861eb80a84e59995571c0da1b
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_12\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC6 WDR76 KCNN3 PYCR1 MMP9 TICRR USP37	2.46e-05	161	236	7	1d446f5ba57d84949823a35cbedaee8f448fe40f
ToppCell	mild-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CCDC125 TTLL3 TRPM2 WDR76 MMP9 MEGF9	2.52e-05	109	236	6	2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NAV1 PYCR1 MMP2 GPR17 LAD1 E2F8	2.66e-05	110	236	6	ee45592e936d32881c0f3429c21360670e5b3ce3
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NAV1 PYCR1 MMP2 GPR17 LAD1 E2F8	2.66e-05	110	236	6	b9c8014fd2820e5ea28a7e02fd24227b99e71eb3
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	STOML1 GLS DENND5B DNAH3 ASAP3 POM121L2 TNS2 FAM131A BTBD7 HMGXB3 SNTA1	5.00e-06	194	231	11	4126_DN
Drug	Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A	EPPK1 SYT12 KRI1 RYR2 NDST1 LARP1 LAMB3 TNS2 BTBD2 GRTP1 BTBD7	6.37e-06	199	231	11	2220_DN
Drug	Ethamivan [304-84-7]; Up 200; 18uM; HL60; HG-U133A	GCDH TULP3 RRP12 UMPS DNAH3 ANK2 POM121L2 ZNF783 ARG2 SNTA1 ARHGAP33	6.68e-06	200	231	11	1730_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	MBTPS1 PDK1 CHRNA5 RRP12 DESI1 NDST1 ANK2 LARP1 RGS14 TNS1	2.35e-05	188	231	10	6186_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	CHRNA5 SYNJ2 STOML1 TBCD ANK2 POM121L2 SYDE1 ZNF783 HAAO TNS1	3.08e-05	194	231	10	2485_DN
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A	STOML1 MMP9 KIF26B ASAP3 LAMA2 RELB LCP2 IFI35 PRAF2 TNS1	3.21e-05	195	231	10	5884_UP
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	ABCA3 SPTBN1 MCM10 ARAP1 POLH ASAP3 SIAH1 E2F8 RGS14 SNTA1	3.21e-05	195	231	10	5070_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	TRPM2 GLS ASAP3 POM121L2 TNS2 TRIM68 SYDE1 BTBD7 HAAO TNS1	3.36e-05	196	231	10	3360_UP
Drug	Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A	ABCA3 STOML1 MMP2 ARAP1 GPR17 SYDE1 ZNF783 SLC3A1 ARG2 TNS1	3.50e-05	197	231	10	7292_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	IFT140 SPTBN1 GLS HSD17B1 PLTP ARAP1 LAMB3 ABCF2 ZNF783 DZANK1	3.50e-05	197	231	10	6936_UP
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	LDLRAP1 EVPL RYR2 SYNJ2 STOML1 LAMA5 ZNF783 ARG2 MEGF9 HMGXB3	3.66e-05	198	231	10	7443_DN
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; PC3; HT_HG-U133A	IFT140 RYR2 RRP12 STOML1 MMP9 DNAH3 POLH ASAP3 SLC3A1 RGS14	3.66e-05	198	231	10	6696_DN
Drug	2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A	SPTBN1 KRI1 EVPL RRP12 MMP19 TCEA2 NDST1 BTBD2 RGS14 UBE2O	3.82e-05	199	231	10	346_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A	SPTBN1 RYR2 LPIN1 SYNJ2 ASAP3 ARG2 RGS14 CSF1R BTBD7 SNTA1	3.82e-05	199	231	10	5787_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; HL60; HT_HG-U133A	IFT140 GCDH SGMS1 MMP9 PLTP ARAP1 POM121L2 TNS2 FRYL TRIM68	3.82e-05	199	231	10	2503_DN
Disease	Colorectal Carcinoma	ABCA3 TTLL3 SPTBN2 PSMC5 LPIN1 ABCD3 UMPS MMP2 SHANK1 UNC13B DNAH3 PMS2 ANK2 ASAP3 LAMB3 GRIK3 CUBN TYMP LAS1L	2.61e-06	702	228	19	C0009402
Disease	alpha-Mannosidosis	MAN2C1 MAN2B1	5.94e-05	2	228	2	C0024748
Disease	pyoderma gangrenosum (is_marker_for)	MMP2 MMP9	5.94e-05	2	228	2	DOID:8553 (is_marker_for)
Disease	Sweet syndrome (is_marker_for)	MMP2 MMP9	5.94e-05	2	228	2	DOID:0080746 (is_marker_for)
Disease	combined oxidative phosphorylation deficiency 20 (implicated_via_orthology)	VARS1 VARS2	5.94e-05	2	228	2	DOID:0111478 (implicated_via_orthology)
Disease	lymphangioleiomyomatosis (is_marker_for)	ACSS2 GLS MMP9	9.51e-05	12	228	3	DOID:3319 (is_marker_for)
Disease	Malignant neoplasm of breast	ABCA3 MAN2C1 ETV4 SULF2 SYNJ2 UMPS MMP2 BCAR3 MMP9 ANK2 WDR88 ZSWIM5 POLH LAMA2 FAM131A GRIK3 CUBN CSF1R IGFBP7 TNS1 TP53BP1	9.94e-05	1074	228	21	C0006142
Disease	IGF-1 measurement	IFT140 SPTBN2 PSMC5 WDR76 MIDEAS CYP26C1 CMAHP DOCK3 DENND5B TCEA2 TICRR USP37 PAH	1.21e-04	488	228	13	EFO_0004627
Disease	heart valve disease (is_marker_for)	MMP2 MMP9	1.77e-04	3	228	2	DOID:4079 (is_marker_for)
Disease	pulmonary embolism (implicated_via_orthology)	MMP2 MMP9	1.77e-04	3	228	2	DOID:9477 (implicated_via_orthology)
Disease	Familial hypercholesterolemia - homozygous	LDLRAP1 ABCG5	1.77e-04	3	228	2	C0342881
Disease	Sturge-Weber syndrome (is_marker_for)	MMP2 MMP9	1.77e-04	3	228	2	DOID:0111563 (is_marker_for)
Disease	Lupus Nephritis	MMP2 MMP9	3.53e-04	4	228	2	C0024143
Disease	thoracic aortic aneurysm (biomarker_via_orthology)	MMP2 MMP9	3.53e-04	4	228	2	DOID:14004 (biomarker_via_orthology)
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTBN1 SPTBN2	3.53e-04	4	228	2	DOID:0050882 (implicated_via_orthology)
Disease	intracranial aneurysm (implicated_via_orthology)	ARHGEF17 MMP9	3.53e-04	4	228	2	DOID:10941 (implicated_via_orthology)
Disease	stomach carcinoma (biomarker_via_orthology)	MMP2 MMP9	3.53e-04	4	228	2	DOID:5517 (biomarker_via_orthology)
Disease	renal hypertension (implicated_via_orthology)	MMP2 MMP9	5.85e-04	5	228	2	DOID:1073 (implicated_via_orthology)
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	5.85e-04	5	228	2	C0206630
Disease	Aortic Rupture	MMP2 MMP9	5.85e-04	5	228	2	C0003496
Disease	adrenoleukodystrophy (is_marker_for)	MMP2 MMP9	5.85e-04	5	228	2	DOID:10588 (is_marker_for)
Disease	Aortic Aneurysm, Ruptured	MMP2 MMP9	5.85e-04	5	228	2	C0741160
Disease	Liver carcinoma	MBTPS1 CYP4A11 MCM10 WDR76 ANLN UMPS MMP2 MMP9 TICRR E2F8 CCNB1 PITPNM3	6.31e-04	507	228	12	C2239176
Disease	alcohol use disorder (implicated_via_orthology)	ACSS2 RYR2 UNC79 UNC13B ARL6IP5 SMARCD2 PRAF2	8.39e-04	195	228	7	DOID:1574 (implicated_via_orthology)
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	8.74e-04	6	228	2	C0334488
Disease	pulmonary emphysema (biomarker_via_orthology)	MMP2 MMP9	8.74e-04	6	228	2	DOID:9675 (biomarker_via_orthology)
Disease	X-21829 measurement	CYP4A11 HMGCS2	8.74e-04	6	228	2	EFO_0800830
Disease	Aortic Diseases	MMP2 MMP9	8.74e-04	6	228	2	C0003493
Disease	X-18922 measurement	CYP4A11 HMGCS2	8.74e-04	6	228	2	EFO_0800797
Disease	X-14939 measurement	CYP4A11 CYP4A22	8.74e-04	6	228	2	EFO_0800747
Disease	Neointima Formation	MMP2 MMP9	8.74e-04	6	228	2	C2936381
Disease	Neointima	MMP2 MMP9	8.74e-04	6	228	2	C2936380
Disease	level of Sterol ester (27:1/18:2) in blood serum	NKPD1 RELB ANKRD17	1.04e-03	26	228	3	OBA_2045194
Disease	Liver Cirrhosis, Experimental	PLEKHH1 PXDN GLS PYCR1 MMP2 MMP9 ABCG5 PLTP U2SURP LCP2 IFI35 CSF1R IGFBP7 PRAF2 PCK2	1.08e-03	774	228	15	C0023893
Disease	orofacial cleft (is_implicated_in)	ACSS2 LOXHD1	1.22e-03	7	228	2	DOID:0050567 (is_implicated_in)
Disease	Aortic Aneurysm, Thoracic	MMP2 MMP9	1.22e-03	7	228	2	C0162872
Disease	long QT syndrome (is_implicated_in)	ANK2 SNTA1	1.22e-03	7	228	2	DOID:2843 (is_implicated_in)
Disease	Aortic Aneurysm, Thoracoabdominal	MMP2 MMP9	1.22e-03	7	228	2	C0340630
Disease	myoclonic-atonic epilepsy (implicated_via_orthology)	VARS1 VARS2	1.22e-03	7	228	2	DOID:0060475 (implicated_via_orthology)
Disease	cardiomyopathy (is_marker_for)	MMP2 MMP9	1.22e-03	7	228	2	DOID:0050700 (is_marker_for)
Disease	Child Development Disorders, Specific	KCNT1 TBCD WDFY4	1.43e-03	29	228	3	C0085997
Disease	Child Development Deviations	KCNT1 TBCD WDFY4	1.43e-03	29	228	3	C0085996
Disease	Neoplasm Metastasis	ETV4 MMP2 MMP9 PMS2 TYMP E2F8 CSF1R	1.56e-03	217	228	7	C0027627
Disease	Developmental Disabilities	KCNT1 TBCD WDFY4	1.58e-03	30	228	3	C0008073
Disease	Bone neoplasms	MMP2 MMP9	1.61e-03	8	228	2	C0005967
Disease	mitochondrial encephalomyopathy (implicated_via_orthology)	VARS1 VARS2	1.61e-03	8	228	2	DOID:890 (implicated_via_orthology)
Disease	Malignant Bone Neoplasm	MMP2 MMP9	1.61e-03	8	228	2	C0279530
Disease	urate measurement	SYT12 QRICH2 CHRNA5 AK3 EVX2 NAV1 CMAHP VARS1 DOCK3 DNAH3 U2SURP ARL6IP5 VARS2 CUBN RGS14 HERC4	1.71e-03	895	228	16	EFO_0004531
Disease	arteriosclerosis (is_implicated_in)	MMP2 MMP9 ABCG5	1.74e-03	31	228	3	DOID:2349 (is_implicated_in)
Disease	hypertension (biomarker_via_orthology)	CYP4A11 KCNJ11 MMP2 MMP9 AGTRAP CYP4A22 ARG2	2.01e-03	227	228	7	DOID:10763 (biomarker_via_orthology)
Disease	neutral ceramidase measurement	SGMS1 WDFY4	2.06e-03	9	228	2	EFO_0008247
Disease	Marfan Syndrome, Type I	MMP2 MMP9	2.06e-03	9	228	2	C4721845
Disease	abdominal aortic aneurysm (implicated_via_orthology)	MMP2 MMP9	2.06e-03	9	228	2	DOID:7693 (implicated_via_orthology)
Disease	abdominal aortic aneurysm (is_marker_for)	MMP2 MMP9	2.57e-03	10	228	2	DOID:7693 (is_marker_for)
Disease	Aortic Aneurysm, Abdominal	DAB2IP MMP9	2.57e-03	10	228	2	C0162871
Disease	morbid obesity (is_marker_for)	ACSS2 LPIN1	2.57e-03	10	228	2	DOID:11981 (is_marker_for)
Disease	cholesteatoma (is_marker_for)	MMP2 MMP9	2.57e-03	10	228	2	DOID:869 (is_marker_for)
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	RYR2 ANK2	2.57e-03	10	228	2	C1631597
Disease	wellbeing measurement, alcohol consumption measurement	RRAGC DST PABPC4L RELB	2.62e-03	74	228	4	EFO_0007869, EFO_0007878
Disease	esophagus squamous cell carcinoma (is_marker_for)	DAB2IP CHRNA5 MMP2 MMP9	2.62e-03	74	228	4	DOID:3748 (is_marker_for)
Disease	Mammary Carcinoma, Human	MAN2C1 ETV4 SYNJ2 UMPS MMP2 BCAR3 MMP9 ZSWIM5 CSF1R IGFBP7 TP53BP1	2.73e-03	525	228	11	C4704874
Disease	Mammary Neoplasms, Human	MAN2C1 ETV4 SYNJ2 UMPS MMP2 BCAR3 MMP9 ZSWIM5 CSF1R IGFBP7 TP53BP1	2.73e-03	525	228	11	C1257931
Disease	Mammary Neoplasms	MAN2C1 ETV4 SYNJ2 UMPS MMP2 BCAR3 MMP9 ZSWIM5 CSF1R IGFBP7 TP53BP1	2.81e-03	527	228	11	C1458155
Disease	pulmonary function measurement, forced expiratory volume	CHRNA5 SLC6A11 TNS1	2.91e-03	37	228	3	EFO_0003892, EFO_0004314
Disease	Leukoencephalopathy	TYMP CSF1R	3.12e-03	11	228	2	C0270612
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CYP4A11 CYP4A22	3.12e-03	11	228	2	DOID:0110861 (biomarker_via_orthology)
Disease	X-21607 measurement	CYP4A11 MIDEAS	3.12e-03	11	228	2	EFO_0800819
Disease	Marfan Syndrome	MMP2 MMP9	3.12e-03	11	228	2	C0024796
Disease	Prostatic Neoplasms	DAB2IP MBTPS1 ETV4 UMPS HSD17B1 MMP9 ABCG5 PCDH11Y SHBG ARG2 IGFBP7 ALOXE3	3.22e-03	616	228	12	C0033578
Disease	Malignant neoplasm of prostate	DAB2IP MBTPS1 ETV4 UMPS HSD17B1 MMP9 ABCG5 PCDH11Y SHBG ARG2 IGFBP7 ALOXE3	3.22e-03	616	228	12	C0376358
Disease	renal cell carcinoma (is_marker_for)	MMP2 MMP9 TYMP CCNB1 CSF1R	3.23e-03	128	228	5	DOID:4450 (is_marker_for)
Disease	Breast Carcinoma	MAN2C1 ETV4 SYNJ2 UMPS MMP2 BCAR3 MMP9 ZSWIM5 CSF1R IGFBP7 TP53BP1	3.29e-03	538	228	11	C0678222
Disease	ductal carcinoma in situ (is_marker_for)	MMP2 MMP9 TYMP	3.39e-03	39	228	3	DOID:0060074 (is_marker_for)
Disease	Hypercholesterolemia	LDLRAP1 ABCG5 MTTP	3.39e-03	39	228	3	C0020443
Disease	Centriacinar Emphysema	MMP2 MMP9	3.73e-03	12	228	2	C0221227
Disease	Panacinar Emphysema	MMP2 MMP9	3.73e-03	12	228	2	C0264393
Disease	hyperinsulinism (is_implicated_in)	KCNJ11 MTTP	3.73e-03	12	228	2	DOID:2018 (is_implicated_in)
Disease	Focal Emphysema	MMP2 MMP9	3.73e-03	12	228	2	C2350878
Disease	intracranial aneurysm (is_implicated_in)	MMP2 MMP9	3.73e-03	12	228	2	DOID:10941 (is_implicated_in)
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	MMP2 MMP9	3.73e-03	12	228	2	DOID:1312 (biomarker_via_orthology)
Disease	prediabetes syndrome (biomarker_via_orthology)	KCNJ11 RELB	3.73e-03	12	228	2	DOID:11716 (biomarker_via_orthology)
Disease	cholangiocarcinoma (biomarker_via_orthology)	MMP2 MMP9	4.38e-03	13	228	2	DOID:4947 (biomarker_via_orthology)
Disease	interleukin 6 receptor subunit alpha measurement	KCNN3 SHE	4.38e-03	13	228	2	EFO_0008187
Disease	intracranial aneurysm (biomarker_via_orthology)	MMP2 MMP9	4.38e-03	13	228	2	DOID:10941 (biomarker_via_orthology)
Disease	skin melanoma (is_marker_for)	MMP2 MMP9	4.38e-03	13	228	2	DOID:8923 (is_marker_for)
Disease	alcohol use disorder (biomarker_via_orthology)	MMP2 MMP9	5.09e-03	14	228	2	DOID:1574 (biomarker_via_orthology)
Disease	Malformations of Cortical Development	TBCD NDST1	5.09e-03	14	228	2	C1955869
Disease	Diabetic Neuralgia	MMP2 MMP9	5.09e-03	14	228	2	C0751074
Disease	Diabetic Neuropathies	MMP2 MMP9	5.09e-03	14	228	2	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	MMP2 MMP9	5.09e-03	14	228	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	MMP2 MMP9	5.09e-03	14	228	2	C0271673
Disease	Diabetic Mononeuropathy	MMP2 MMP9	5.09e-03	14	228	2	C0271678
Disease	Diabetic Autonomic Neuropathy	MMP2 MMP9	5.09e-03	14	228	2	C0271686
Disease	Diabetic Amyotrophy	MMP2 MMP9	5.09e-03	14	228	2	C0271685
Disease	Diabetic Polyneuropathies	MMP2 MMP9	5.09e-03	14	228	2	C0271680
Disease	intracranial aneurysm (is_marker_for)	MMP2 MMP9	5.09e-03	14	228	2	DOID:10941 (is_marker_for)
Disease	Diabetic Asymmetric Polyneuropathy	MMP2 MMP9	5.09e-03	14	228	2	C0393835
Disease	Cortical Dysplasia	TBCD NDST1	5.09e-03	14	228	2	C0431380
Disease	apolipoprotein B measurement	LDLRAP1 KRI1 MIDEAS SGMS1 CYP26C1 NKPD1 CMAHP ABCG5 PLTP RELB IGFBP7 MTTP	5.73e-03	663	228	12	EFO_0004615
Disease	relapsing-remitting multiple sclerosis (is_marker_for)	MMP9 MMP19	5.84e-03	15	228	2	DOID:2378 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
GINLRKIAELMPGAS	PSMC5	341	P62195
KLLTGELLPTDGMIR	ABCF2	441	Q9UG63
GKTLALARTMDIPRS	ALDH8A1	96	Q9H2A2
FPLDSLMKGQLRDGR	ASAP3	126	Q8TDY4
PRLTALQRDGGAILM	ARHGEF40	726	Q8TER5
PAAIREAGLMKRLSS	ARG2	46	P78540
MGGRRLSLAPDDSLL	HAAO	241	P46952
GRPDVAKRLSLTMGG	BCAR3	281	O75815
LTPRGMRALGRALAT	CARMIL2	316	Q6F5E8
LMERGLHSPTAGKRF	EVX2	11	Q03828
RKPPREMLKLSGSDS	GPR17	11	Q13304
DGRSLPKGIMVLLSI	CYP4A11	401	Q02928
SGGMRRKLSIGIALI	ABCA3	666	Q99758
MKELGIGRASRKLGR	FABP12	21	A6NFH5
RVSSMPIELLTKGGL	DNHD1	756	Q96M86
APGLPKTRSGKIMRR	ACSS2	651	Q9NR19
ESEGGRTPLMKAARA	ANKRD17	626	O75179
SRTGSKLGISPLMLA	ANKRD17	1211	O75179
GSLREALIGPLGKLM	ETV4	26	P43268
MEALMARGALTGPLR	MMP2	1	P08253
GLGAMSRLPSAKSRI	MTUS2	771	Q5JR59
RMDTRLPGILRKDSS	QRICH2	1606	Q9H0J4
LSRPLLGTKGVLRMA	RIMBP3B	981	A6NNM3
LSRPLLGTKGVLRMA	RIMBP3C	981	A6NJZ7
RKRGMPDVLGELNSS	RELB	411	Q01201
VRLLLPGKMGKLAEA	H2BW2	121	P0C1H6
GSGMLRDLLLRSPAG	GLS	6	O94925
GGVKMGLPRRLAVRL	PYCR1	191	P32322
MSDRGGGVPLRKIDR	PDK1	316	Q15118
VTEMRKLFGGPGSRR	ARHGEF17	126	Q96PE2
MDALKSAGRALIRSP	LDLRAP1	1	Q5SW96
GRLSFMKEPKSTRGL	ANK2	1426	Q01484
PGELARRQMSLTEKG	DAB2IP	886	Q5VWQ8
RVAEMRGESKSLGPA	MMP9	56	P14780
ALRSGRGKMLLFSGR	MMP9	616	P14780
LILPGRMSKGALNRI	MTX3	136	Q5HYI7
LRRKMDADGFLPITL	LARP1	426	Q6PKG0
KSLAPGMALGSGRRL	LAD1	241	O00515
GMALGSGRRLVSEKA	LAD1	246	O00515
KGRKLTRLPGELSNM	LRRD1	636	A4D1F6
GDMAGLERPRAASKL	KIAA1671	311	Q9BY89
GRGLLRKMDTTTPLK	NELFA	201	Q9H3P2
SMKQALIASARRLPG	MBTPS1	441	Q14703
TQRLPRAIGMSLAKE	AUH	221	Q13825
VGRASDYGMKLPILR	MLEC	76	Q14165
LSGDTLPREKGRMRF	DST	76	Q03001
RKTPTFLGATAGMRL	ENTPD8	116	Q5MY95
PASLGMKLRGLLDRK	ALOXE3	226	Q9BYJ1
SVAVPASLLGMRRGL	ANLN	116	Q9NQW6
TLLSLRGKARTGGPM	EIF4E1B	41	A6NMX2
RPMGSPRLGIASLSK	KIF26B	1061	Q2KJY2
SASGRPPLKRMERAS	KIAA1109	3621	Q2LD37
MRSPIKRALGLADLE	HERC1	2576	Q15751
MARAKLPRSPSEGKA	KCNT1	1	Q5JUK3
RLLRAVIMGAPGSGK	AK3	6	Q9UIJ7
APFTKMRIRIDGLGS	LOXHD1	1611	Q8IVV2
SGGRRMTLRDDQPAK	DCLK3	306	Q9C098
KAPLALERGLRGTHM	HMGCS2	221	P54868
GKPSLLAAARPMRAI	HMGXB3	506	Q12766
LASARGPLRKRSVPM	KCNJ11	361	Q14654
AVLFIPAMKRSLAGR	GP6	71	Q9HCN6
IGVRKGGTRALLEML	HS3ST5	96	Q8IZT8
LSMEGRKGAQLPRIF	PCK2	516	Q16822
RTGLELSRDPAGRMK	PLTP	126	P55058
VRELLPGSVMLGFAR	IFI35	171	P80217
SGGVMKPLSRLSASR	KCNN3	181	Q9UGI6
LLPMTVSGRVLGLAE	MMP19	11	Q99542
LELKTTEAGPRLMSG	MTTP	256	P55157
AMGRCRKDPLSGLLL	EVPL	1996	Q92817
RLMSIVSALFPKGSR	FRYL	381	O94915
LTGSDRIPILGMKSL	HERC4	991	Q5GLZ8
NRLSRLLKPGGMVLL	METTL2B	276	Q6P1Q9
DMPTLTDKGRGRFAL	NDST1	121	P52848
KRGSVDRMRGLDPST	LPIN1	121	Q14693
ERAMRSLPSLGGLAL	MEGF9	6	Q9H1U4
RMLSELPALGISGIR	LAS1L	401	Q9Y4W2
RAKKARLLGPTVMLG	KRI1	651	Q8N9T8
GGLPTLRNLSMKARP	LAMA2	2471	P24043
RLEGAPATMTPKLGR	MCM10	616	Q7L590
GHLMGKALRDPTVTR	LAMA5	271	O15230
MERPSLRALLLGAAG	IGFBP7	1	Q16270
SKRARPAEVGGMQLR	DUT	101	P33316
GRRLAKGPELMAIEG	CASKIN2	636	Q8WXE0
RGLPVSGTKTALMDR	MYOCD	386	Q8IZQ8
MSTAVLENPGLGRKL	PAH	1	P00439
LQKRTVEDRMLLPGG	OLFML1	241	Q6UWY5
PRSLGSAMRKIVSIL	HMCN1	4916	Q96RW7
RSLARLKPTMTLEEG	NUTM1	246	Q86Y26
LPGSAMGGLETSLRR	LRRC32	551	Q14392
PRGKLAGLLRTFMRS	ARHGAP33	281	O14559
PLIRSSGDSMFIKLR	CUBN	1246	O60494
MAARGSGPRALRLLL	CHRNA5	1	P30532
ARLRLKRTSSMDSPG	APBB3	431	O95704
EMKILRALNFGLGRP	CCNB1	286	P14635
RRKAEAMLGPSLSPG	CSF1R	676	P07333
GRALVRGPSSLMKKA	DRAXIN	151	Q8NBI3
GMLPLGSRLTSVSAK	FAM124B	261	Q9H5Z6
SRAKRPLMVLGSQAL	ILVBL	281	A1L0T0
MTKRLALSDSPDGRP	KCNC1	151	P48547
LEINRAGRKPLRGMS	KCNC1	496	P48547
PRSKKTFGQRLLGML	CCDC125	371	Q86Z20
GRGNIISPSRMLDKS	DACT2	456	Q5SW24
LTRKFMDLVRSAPGG	E2F6	71	O75461
REPAGERGSKRASML	E2F8	596	A0AVK6
PMIFNRGLAITRKLG	DOCK3	396	Q8IZD9
IMSKLDRRRKGLFGP	DNAH3	2116	Q8TD57
MALRGVSVRLLSRGP	GCDH	1	Q92947
FLLEKGMRGLSAPRI	GCDH	236	Q92947
LTRRKEELPMKGGTL	FAM193B	446	Q96PV7
KMSRREAGLILGVSP	DNAJC15	91	Q9Y5T4
RSPLADLTLKGMVTG	FGGY	396	Q96C11
FLPDMKRRGSGRVLV	HSD17B1	126	P14061
ERGARMKSVGILSPS	DENND11	146	A4D1U4
MGDLPGLVRLSIALR	CNRIP1	1	Q96F85
DGRSLPKGIMVLLSI	CYP4A22	401	Q5TCH4
KLPAVGALMERLGVL	GRTP1	211	Q5TC63
LSKGLARRLSPIMLG	DESI1	16	Q6ICB0
ARRLSPIMLGKQLEG	DESI1	21	Q6ICB0
RKLPGSDVSGRLMGS	FBXO28	221	Q9NVF7
LGPERRKSDSGVMLP	DENND5B	826	Q6ZUT9
GDTVAMLPKSRRALT	FAM131A	81	Q6UXB0
GKTTLLDAMSGRLGR	ABCG5	91	Q9H222
RKSLPMLSSGLTGRR	BAHD1	6	Q8TBE0
AMAKRRGEGLPSRKT	BAHD1	721	Q8TBE0
RDRASTLPLPKGSMG	CYP26C1	41	Q6V0L0
MKRIADREPNLLSGT	BTBD7	476	Q9P203
PAPLGKDASLRRMSS	MGARP	21	Q8TDB4
RLLKDDGRGVSEPLM	MAN2B1	816	O00754
GGPTQTMLDRLKRLS	MAN2C1	466	Q9NTJ4
LRGLPVSGTKSMLLE	MAMSTR	186	Q6ZN01
LATKRAREDSGMVPL	MIDEAS	511	Q6PJG2
LLSLTPSRVMDGKRI	KHNYN	506	O15037
GTGSPKLVALRLEMS	LAMB3	761	Q13751
FRALIAEPRMGKLIS	DZANK1	501	Q9NVP4
SGPMEVLRKGSLRLR	FAM83H	956	Q6ZRV2
SELMPKALSTRIIGG	GRIK3	626	Q13003
PRRRKGLTTGLMTQA	FAM27E3	26	Q08E93
GKALGLIRFPLMTIE	BTBD2	311	Q9BX70
ELGRIKNVMPLSAGL	RYR2	1556	Q92736
KGLLAAGTDRGRVAM	IFT140	336	Q96RY7
RTRIEGLLAAFPKLM	ARCN1	26	P48444
IRLMDSVALKGGRGS	CZIB	46	Q9NWV4
SKLRARDGGERISMP	MAP3K11	481	Q16584
SGIGKMTALELARRG	DHRS13	46	Q6UX07
EMNGRILGSKPLSIA	PABPC4L	351	P0CB38
KLLVLASDGGLMPAR	PCDH11Y	356	Q9BZA8
MKGSLGRLLLRATSL	OR7C2	296	O60412
ADLIVMLRGPGINKR	POTEA	81	Q6S8J7
RLLVLMSSPYKGEGR	MROH2A	581	A6NES4
GVRKGGTRALLEMLS	HS3ST1	61	O14792
RRLMETNLSKLRSGP	NRIP3	66	Q9NQ35
SLARRKPTMTLEEGL	NUTM2A	366	Q8IVF1
SLARRKPTMTLEEGL	NUTM2B	366	A6NNL0
SLARRKPTMTLEEGL	NUTM2E	366	B1AL46
GSTLSLAERPKGMIR	NAV1	1031	Q8NEY1
LAERPKGMIRSGSFR	NAV1	1036	Q8NEY1
MSKLGRAARGLRKPE	MRPL11	1	Q9Y3B7
PFRGLMKLGTVERRG	PLEKHM1	531	Q9Y4G2
RLFPGRVSVDLMLGL	RSAD1	186	Q9HA92
MAEPLLRKTFSRLRG	SYDE1	1	Q6ZW31
LSLGMKGRARGTAPK	SYDE2	201	Q5VT97
ARMVMLGLKLTGRLP	VARS1	831	P26640
GRKMSKSLGNVLDPR	VARS2	656	Q5ST30
MGRELDLAPYGTLRK	SYT12	116	Q8IV01
GADSSKPRILLMGLR	RRAGC	56	Q9HB90
LEGRRPPLMASGKSL	POLR1A	921	O95602
MASGRRAPRTGLLEL	SNTA1	1	Q13424
MALSKGLRLLGRLGA	SYNJ2	1	O15056
RKMLRGSGLPAVSRE	TCAF2	466	A6NFQ2
SQRAFMKEGLLPLRG	TOGARAM2	391	Q6ZUX3
RMGLIRAVSALKPPS	NKPD1	531	Q17RQ9
LSRPLLGTKGVLRMA	RIMBP3	981	Q9UFD9
TPLKREMLPSGRGIL	PIWIL2	86	Q8TC59
DMKGTLRKFIGRIPS	OR7G2	296	Q8NG99
GLKRTPMGIVLDALE	ARL6IP5	156	O75915
LALLPLKITFRSMGG	EPPK1	226	P58107
TSKRHPIMRIALGGL	SHBG	161	P04278
LDLRGNRLKVMPFAG	SLITRK2	186	Q9H156
LATARGMRDGAATKP	SMIM32	36	A0A1B0GUA5
RGPLGSIRNLAMEKV	SIAH1	76	Q8IUQ4
GLSSMENRRPLLRKG	SMCR5	111	Q8TEV8
ISGLPAKMRIRLSTN	SLC3A1	611	Q07837
VSKPGALRRSLSRSM	TCAP	146	O15273
MGSELIGRLAPRLGL	ORC6	1	Q9Y5N6
LFSQMPIRKIRSLGG	POLH	246	Q9Y253
GRGSISARKTMAPIA	POM121L2	956	Q96KW2
KGLARTLGMAISERP	RRP12	641	Q5JTH9
GRLRFSEIPMKLAGL	SMARCD2	366	Q92925
LMTPSKLRGRALGAS	SHANK1	1751	Q9Y566
SGERLPKPTKGRMRI	SPTBN1	96	Q01082
LRGLTPRKNDIGDAM	U2SURP	546	O15042
GLFLTRLRRPIGKMT	ABCD3	241	P28288
MKFREDRSLLGLGLP	ARAP1	1281	Q96P48
RPGATLDLGRMLKDR	CMAHP	296	Q9Y471
LMGSLVDKRGNILIP	CNDP2	246	Q96KP4
KRDILMDRILPDSGG	CNOT1	231	A5YKK6
RFGVGMAILSLLLKP	AGTRAP	86	Q6RW13
LSRNSIGRDIPKMLE	MRPL1	221	Q9BYD6
IPGRRSSGKLMSTDK	ZSWIM5	1091	Q9P217
GEMLLRSGIKLSSEP	TICRR	256	Q7Z2Z1
KVRLLRLHPGMGLKG	TRIM68	81	Q6AZZ1
AEKSRALLPMAQRGS	TSNARE1	361	Q96NA8
GTMARALGRFKLSIP	WDR88	36	Q6ZMY6
KRGLDMEGILRVPGS	ARHGAP40	301	Q5TG30
GLRSLGEKMKLLPQR	RNF112	106	Q9ULX5
LRGEMSGRLGPLKLT	SPTBN2	686	O15020
MITGKGVPDLNTRLL	SPO11	246	Q9Y5K1
MRGELEGKPILLNGR	TNN	426	Q9UQP3
NKIESIGLKRTPMGL	PRAF2	151	O60831
IGLKRTPMGLLLEAL	PRAF2	156	O60831
ELRPLGAYMSGRLKV	STOML1	366	Q9UBI4
PLKRSGSMEQRLASL	TRPM2	1166	O94759
VKGPRLRMPTFGLSL	PRX	386	Q9BXM0
LPEKRRMSVGDRAGS	TNS1	1386	Q9HBL0
PLLRGLFGVAGKMRV	PXDN	1116	Q92626
RMDLFSALIKGPTRT	UBE2O	981	Q9C0C9
ELSMTKGRPRGLRLR	WDFY4	2961	Q6ZS81
MAVARAALGPLVTGL	UMPS	1	P11172
STDLKMRGKLGVSPR	SLC6A11	591	P48066
LRRIMKLIAGGGLSI	SGMS1	256	Q86VZ5
LGLAVMPLRDVTAKG	UNC13B	1526	O14795
ALARPGLTIRDMLAG	RGS14	316	O43566
SPRASMGVLSGKRKL	TP53BP1	1656	Q12888
RRRGLGDMKLGKPLL	TTLL3	711	Q9Y4R7
GSPRAIKRGVSMSSL	PLEKHH1	521	Q9ULM0
GSPLGLVLAMRRTVL	PITPNM3	401	Q9BZ71
GLRLAPLALVEVGMT	nan	81	Q6Q795
EPRRSPLGQKRGMLS	PMS2	441	P54278
AMPLFGRTKKRTLGA	ZNF133	151	P52736
VLRPSGAKQSRLMLT	USP37	61	Q86T82
RSMRLLKVDPSGVSL	WDR76	216	Q9H967
ARPGMVLSDIKSIGL	ZGRF1	1401	Q86YA3
SDMETPLKAGPFRRL	TRIM16	481	O95361
KARERGRGMPLPTSS	TCEA2	86	Q15560
AKGIGRMAGRLPRAL	TBCD	381	Q9BTW9
TLLGRAGRGPLMAAK	SHE	26	Q5VZ18
RQGLAKGMPVRLLSE	ZYG11A	411	Q6WRX3
IIRDKRGMDRGLFPT	TULP3	206	O75386
LPELIRMKRDGGRLS	TYMP	36	P19971
MRLGGSRALSNLVPK	SULF2	481	Q8IWU5
MKSSGPVERLLRALG	TNS2	1	Q63HR2
ETPFGKMRGSHLRLL	TSR3	131	Q9UJK0
ISPDGKMLLSAGRTI	WDR43	176	Q15061
GGRALVGRRPAASKM	ZNF783	421	Q6ZMS7
GQPLRMRGATKSSLL	UNC79	1966	Q9P2D8
RLAMGVAASLPGLVL	GARIN5B	66	Q8N5Q1
RKMPLLLIDGKNRGS	LCP2	506	Q13094